Cormorant Asset Management »

Artiva Biotherapeutics shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.0M 104k 10.08
2024-09-30 $1.6M 104k 15.45

More positions owned by Cormorant Asset Management

Bridgebio Oncology Therapeut Com New
Abivax Sa Sponsored Ads (ABVX)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Edgewise Therapeutics (EWTX)
Bright Minds Biosciences Com New (DRUG)
Arcellx Common Stock (ACLX)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Praxis Precision Medicines I Com New (PRAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Pharvaris N V (PHVS)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Gh Research Ordinary Shares (GHRS)

View all positions for Cormorant Asset Management

Top funds holding Artiva Biotherapeutics

RA Capital Management
5AM Venture Management
VR Adviser
venBio Partners
Citadel Advisors
Franklin Resources
BlackRock
Millennium Management
Wellington Management Company
Vanguard Group
Bnp Paribas Arbitrage, Snc
Geode Capital Management
Alyeska Investment Group
Renaissance Technologies
State Street Corporation

View all funds holding Artiva Biotherapeutics